2017 CBA Annual Conference

The Chinese Biopharmaceutical Association (CBA-USA), one of the largest Chinese professional associations in the US, is going to collaborate with MedImmune and co-host its 22rd annual conference on June 25, 2017 at the beautiful campus and the state-of-art conference facility of MedImmune, a member of the AstraZeneca group, the largest biopharma company in the state of Maryland, in Gaithersburg, Maryland. On behalf of the conference organizing committee, we cordially invite Arraybridge to sponsor and exhibit at the event.

The theme of the 22rd CBA annual conference is “Delivering Lifesaving Medicines to Patients through Innovation, Regulatory Reform and Global Partnership”. The theme has been carefully selected to address the critical importance of worldwide collaboration and partnership to capture the great opportunity for the advancement of innovative medicine and biopharmaceuticals in both USA and China.

There will be six sessions:

Plenary Keynote Presentations and Awards

Innovative & Precision Medicine

Regulatory Reform

Global Partnership

Project Think Tank & Entrepreneurship

CBA-SCBA Joint Session

Panel discussions on legal, regulatory aspect and entrepreneurship will also be organized to discuss related issues. The conference provides a perfect venue for people from government, private agencies, biotech and pharmaceutical companies interested in policy issues, business development, and partnership in US and China.

In addition to a compelling conference program, CBA will present its 2017 Brilliant Achievement Award at the Conference, recognizing individuals of exemplary accomplishments in promoting collaboration and global development involving the biopharmaceutical sector in China. We anticipate more than 800 attendees will attend the 2017 Conference.